The diagnosis of acquired demyelinating syndromes of the central nervous system in children requires exclusion of other acute central nervous system disorders. In a 23-site national demyelinating disease study, standardized clinical, laboratory, and magnetic resonance imaging (MRI) data were obtained prospectively from onset, and serially at 3, 6, and 12 months and annually. Twenty of 332 (6%) participants (mean [SD] age, 10.21 [4.32] years; 12 (60%) female) were ultimately diagnosed with vascular disorders (primary or secondary central nervous system vasculitis, vasculopathy, stroke, or migraine, n = 11 children), central nervous system malignancy (n = 3), mitochondrial disease (n = 2), or central nervous system symptoms in the accompaniment of confirmed infection (n = 4). Red flags that may serve to distinguish disorders in the differential of acquired demyelination are described.
BanwellBBar-OrAArnoldDL. Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort study. Lancet Neurol. 2011;10:436–445.
2.
MillerDHWeinshenkerBGFilippiM. Differential diagnosis of suspected multiple sclerosis: a consensus approach. Mult Scler. 2008;14:1157–1174.
3.
WingerchukDMLennonVAPittockSJ. Revised diagnostic criteria for neuromyelitis optica. Neurology. 2006;66:1485–1489.
4.
PolmanCHReingoldSCEdanG. Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria.”Ann Neurol. 2005;58:840–846.
5.
KruppLBBanwellBTenembaumS. Consensus definitions proposed for pediatric multiple sclerosis and related disorders. Neurology. 2007;68:S7–S12.
ScholtenVten HoveWMMacDonaldEA. An unusual presentation of neurosarcoidosis in an 11-year-old boy. Can J Neurol Sci. 2009;36:783–786.
8.
NeilsonDEAdamsMDOrrCM. Infection-triggered familial or recurrent cases of acute necrotizing encephalopathy caused by mutations in a component of the nuclear pore, RANBP2. Am J Hum Genet. 2009;84:44–51.
9.
OuvrierRGrewS. Mechanisms of disease and clinical features of mutations of the gene for mitofusin 2: an important cause of hereditary peripheral neuropathy with striking clinical variability in children and adults. Dev Med Child Neurol. 2010;52:328–330.
10.
DelBRMoggioMRangoM. Mutated mitofusin 2 presents with intrafamilial variability and brain mitochondrial dysfunction. Neurology. 2008;71:1959–1966.
11.
MakhaniNMorrisSKPageAV. A twist on Lyme: the challenge of diagnosing European Lyme neuroborreliosis. J Clin Microbiol. 2011;49:455–457.
12.
TenembaumSChamolesNFejermanN. Acute disseminated encephalomyelitis: a long-term follow-up study of 84 pediatric patients. Neurology. 2002;59:1224–1231.
13.
DalmauJLancasterEMartinez-HernandezE. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol. 2011;10:63–74.
14.
HahnJSLanninWCSarwalMM. Microangiopathy of brain, retina, and inner ear (Susac's syndrome) in an adolescent female presenting as acute disseminated encephalomyelitis. Pediatrics. 2004;114:276–281.
15.
Eluvathingal MuttikkalTJVattothSKeluth ChavanVN. Susac syndrome in a young child. Pediatr Radiol. 2007;37:710–713.
16.
HellmannMASteinerIMosberg-GaliliR. Sudden sensorineural hearing loss in multiple sclerosis: clinical course and possible pathogenesis. Acta Neurol Scand. 2011;124:245–249.
17.
RyanPT. Multiple evanescent white dot syndrome: a review and case report. Clin Exp Optom. 2010;93:324–329.
18.
BremnerFDShallo-HoffmannJRiordan-EvaP. Comparing pupil function with visual function in patients with Leber's hereditary optic neuropathy. Invest Ophthalmol Vis Sci. 1999;40:2528–2534.
19.
KinoshitaAHayashiMMiyamotoK. Inflammatory demyelinating polyradiculitis in a patient with acute disseminated encephalomyelitis (ADEM). J Neurol Neurosurg Psychiatry. 1996;60:87–90.
20.
BanwellBKruppLKennedyJ. Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study. Lancet Neurol. 2007;6:773–781.
21.
DesmondDWMoroneyJTLynchT. The natural history of CADASIL: a pooled analysis of previously published cases. Stroke. 1999;30:1230–1233.
22.
GladstoneJPDodickDW. Migraine and cerebral white matter lesions: when to suspect cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). Neurologist. 2005;11:19–29.
PidcockFSKrishnanCCrawfordTO. Acute transverse myelitis in childhood: center-based analysis of 47 cases. Neurology. 2007;68:1474–1480.
25.
ElbersJHallidayWHawkinsC. Brain biopsy in children with primary small-vessel central nervous system vasculitis. Ann Neurol. 2010;68:602–610.
26.
PayneETRutkaJTHoTK. Treatment leading to dramatic recovery in acute hemorrhagic leukoencephalitis. J Child Neurol. 2007;22:109–113.
27.
HellwigKGoldR. Progressive multifocal leukoencephalopathy and natalizumab. J Neurol. 2011;258:1920–1928.
28.
HaackeEMMakkiMGeY. Characterizing iron deposition in multiple sclerosis lesions using susceptibility weighted imaging. J Magn Reson Imaging. 2009;29:537–544.
29.
BenselerSMSilvermanEAvivRI. Primary central nervous system vasculitis in children. Arthritis Rheum. 2006;54:1291–1297.
30.
MillerDHWeinshenkerBGFilippiM. Differential diagnosis of suspected multiple sclerosis: a consensus approach. Mult Scler. 2008;14:1157–1174.
31.
ElbersJBenselerSM. Central nervous system vasculitis in children. Curr Opin Rheumatol. 2008; 20:47–54.
32.
GoodkinDERooneyWDSloanR. A serial study of new MS lesions and the white matter from which they arise. Neurology. 1998;51:1689–1697.
33.
SheerinFPretoriusPMBrileyD. Differential diagnosis of restricted diffusion confined to the cerebral cortex. Clin Radiol. 2008;63:1245–1253.
34.
D'CruzDPMellor-PitaSJovenB. Transverse myelitis as the first manifestation of systemic lupus erythematosus or lupus-like disease: good functional outcome and relevance of antiphospholipid antibodies. J Rheumatol. 2004;31:280–285.
35.
DaleRCBrilotFBanwellB. Pediatric central nervous system inflammatory demyelination: acute disseminated encephalomyelitis, clinically isolated syndromes, neuromyelitis optica, and multiple sclerosis. Curr Opin Neurol. 2009;22:233–240.
36.
BanwellBGhezziABar-OrA. Multiple sclerosis in children: clinical diagnosis, therapeutic strategies, and future directions. Lancet Neurol. 2007;6:887–902.
37.
LucchinettiCFKiersLO'DuffyA. Risk factors for developing multiple sclerosis after childhood optic neuritis. Neurology. 1997;49:1413–1418.
38.
fDell'OmoRMantovaniAWongR. Natural evolution of fundus autofluorescence findings in multiple evanescent white dot syndrome: a long-term follow-up. Retina. 2010;30:1479–1487.
39.
McAdamLBlaserSBanwellB. Pediatric tumefactive demyelination: Case series and review of the literature. Pediatr Neurol. 2002;26:18–25.
40.
KepesJJ. Large focal tumor-like demyelinating lesions of the brain: intermediate entity between multiple sclerosis and acute disseminated encephalomyelitis? A study of 31 patients [see comments]. Ann Neurol. 1993;33:18–27.
41.
PohlDRostasyKReiberH. CSF characteristics in early-onset multiple sclerosis. Neurology. 2004;63:1966–1967.
42.
AntelJBar-OrA. Roles of immunoglobulins and B cells in multiple sclerosis: from pathogenesis to treatment. J Neuroimmunol. 2006;180:3–8.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
